Hi, I asked this question to the MQSA hotline and this is some of the response that was given:
Under the current (and amended) regulations, if the post-procedure mammogram is logged, reported, and charged as an independent examination, separate from the interventional procedure that precedes it, then the mammogram is subject to all MQSA quality standard requirements. This would include the requirement to be interpreted by a MQSA qualified interpreting physician, preparing a written report of the examination, which after September 10, 2024, must include a federal breast density assessment statement, providing that report to the referring healthcare provider, and communicating the examination results in a summary written in lay language to the patient, which after September 10, 2024, must include a federal breast density notification statement. The lay summary must be specific to the examination and report; for example, if the assessment statement in a report indicates that an examination was a post-procedure mammogram for marker placement, then the lay summary of that report should likewise mention the procedure or the marker placement, but it would not be appropriate to state that the mammogram results were abnormal, worrisome, suspicious for cancer, etc.
------------------------------
Stacie Graham
Lead Coder
Radiology Group, PC, SC
Davenport IA
------------------------------
Original Message:
Sent: 08-27-2024 12:14
From: Heather Rady
Subject: MQSA- Post-Procedure Mammo
Hi all,
Looking for some guidance: one of our mammographers is stating that there is conversation on social media MD groups regarding "any billable mammo must have a density reading under new MQSA regulations." Specifically, they are stating that the post-clip mammo (one view attached to an ultrasound guided biopsy) would require a separate letter for that date of service. This seems odd to me, as they would have already had notification regarding their density (unlikely changed) during their workup. Does anyone have any guidance or operational workflow for this?
In discussion with our Practice Manager, also a previous Breast Coordinator, it would seem the only patient this would apply to would be a patient under the age of 30yoa that might not have had a mammo already.
Would appreciate
Heather L. Rady, MS, ATC
Chief Operating Officer
Radiology Associates of Ridgewood, P.A.
Office: 201-445-8822, ext 119
www.ridgewoodradiology.com
| VALLEY HEALTH SYSTEM LEGAL NOTICE ATTENTION: This email may contain attorney-client privileged, confidential, Individually identifiable health information and other information protected by federal and state privacy laws, including but not limited to HIPAA. Please do not reply to this email with any individually identifiable health information unless such return email has been encrypted or is otherwise secured. If you have received this email in error or believe you are not the intended recipient, please notify us promptly by return email or contact us at privacyoffice@valleyhealth.com, and delete the original and retain no copies. You are hereby on notice that if you received this email by mistake, you may NOT USE, COPY, DISCLOSE or RE-TRANSMIT the information contained in this email or any of its attachments. Unauthorized use or disclosure of any such information may result in civil and/or criminal penalties. |